BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction

Journal:

Science

Published:

2025-07-24

DOI:

10.1126/science.adq2004

Affiliations:

6

Authors:

41

Go to article

Institutions	Authors	Share
BridgeBio, United States of America (USA)	18.000000 18.000000	0.44
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA)	15.500000 15.500000	0.38
Massachusetts General Hospital Cancer Center, United States of America (USA)	4.000000	0.10
Physical and Life Sciences Directorate (PLS), LLNL, United States of America (USA)	2.000000	0.05
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)	1.500000	0.04

Interested in Oncology and Carcinogenesis?